Workiva to report Q3 results, host conference call and webcast
Bitget2026/10/06 13:15Workiva schedules its Q3 2026 results release for Nov. 5, 2026. Conference call to discuss the results set for 5:00 p.m. ET on Nov. 5, 2026. Live webcast on Nov. 5, 2026. Replay available via https://investor.workiva.com/news-events/events. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Workiva Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610060915BIZWIRE_USPR_____20261006_BW620533) on October 06, 2026, and is solely responsible for the information contained therein.
- Workiva schedules its Q3 2026 results release for Nov. 5, 2026.
- Conference call to discuss the results set for 5:00 p.m. ET on Nov. 5, 2026.
- Live webcast on Nov. 5, 2026. Replay available via https://investor.workiva.com/news-events/events.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley raises CME Group price target to $337
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.